11-125954217-T-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 2P and 7B. PM2BP4_StrongBP6_ModerateBP7
The NM_001365077.2(VSIG10L2):āc.1917T>Cā(p.Ser639=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000122 in 1,232,078 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Genomes: š 0.000072 ( 0 hom., cov: 32)
Exomes š: 0.0000037 ( 0 hom. )
Consequence
VSIG10L2
NM_001365077.2 synonymous
NM_001365077.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.47
Genes affected
VSIG10L2 (HGNC:27879): (V-set and immunoglobulin domain containing 10 like 2) Predicted to enable cell adhesion molecule binding activity. Predicted to be involved in cell-cell adhesion. Predicted to be active in cell-cell junction. Predicted to be integral component of plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 11-125954217-T-C is Benign according to our data. Variant chr11-125954217-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 2642515.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-1.47 with no splicing effect.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
VSIG10L2 | NM_001365077.2 | c.1917T>C | p.Ser639= | synonymous_variant | 8/12 | ENST00000686984.1 | |
VSIG10L2 | NM_001391971.1 | c.345+6T>C | splice_donor_region_variant, intron_variant | ||||
VSIG10L2 | NM_001391972.1 | c.221-1398T>C | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
VSIG10L2 | ENST00000686984.1 | c.1917T>C | p.Ser639= | synonymous_variant | 8/12 | NM_001365077.2 | P2 | ||
VSIG10L2 | ENST00000638511.1 | n.283-1398T>C | intron_variant, non_coding_transcript_variant | 1 | |||||
VSIG10L2 | ENST00000638636.2 | c.1917T>C | p.Ser639= | synonymous_variant | 8/10 | 5 | A2 | ||
VSIG10L2 | ENST00000640497.1 | c.333+6T>C | splice_donor_region_variant, intron_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152160Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
11
AN:
152160
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00000370 AC: 4AN: 1079918Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 509830
GnomAD4 exome
AF:
AC:
4
AN:
1079918
Hom.:
Cov.:
31
AF XY:
AC XY:
0
AN XY:
509830
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000723 AC: 11AN: 152160Hom.: 0 Cov.: 32 AF XY: 0.000108 AC XY: 8AN XY: 74348
GnomAD4 genome
AF:
AC:
11
AN:
152160
Hom.:
Cov.:
32
AF XY:
AC XY:
8
AN XY:
74348
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jul 01, 2022 | VSIG10L2: BP4, BP7 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at